ComboMATCH | Colorectal Cancer | Multiple Myeloma, Cancer Information Highlights, 06/05/2023

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI ComboMATCH Will Test New Drug Combinations Guided by Tumor Biology   This new NCI study consists of several phase 2 cancer treatment trials. These trials will test new drug combinations that target certain tumor changes. Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer   A new treatment regimen may help some people with advanced colon or rectal cancer live longer. The regimen includes bevacizumab (Avastin) and the combination of trifluridine and tipiracil (Lonsurf). Motixafortide May Improve Stem Cell Transplants for People with Multiple Myeloma   In a clinical trial of people with multiple myeloma, giving the new drug motixafortide with filgrastim greatly increased the number of stem cells that could be collected when compared with filgrastim alone. The treatment may allow more people with this cancer to collect ideal numbers of stem cells for a transplant. Cancer Survivor Stories Cancer survivors cope in different ways. Read the stories and watch videos of survivors who found a purpose in sharing their experience and giving back to others. PDQ Updates Communication in Cancer Care Good communication between people with cancer, their family, and their health care team has many positive outcomes. Learn about these outcomes and ways to improve communication with your health care team. Soft Tissue Sarcoma Soft tissue sarcoma is a type of cancer that starts in soft tissues like muscle, tendon, fat, lymph vessels, blood vessels, and nerves. Find out about risk factors and symptoms of soft tissue sarcoma and how it is diagnosed and treated.   Also of Interest Vitamin D and Cancer This updated page reviews studies that look at links between a person's vitamin D level or their use of vitamin D supplements and their risk of developing or dying from cancer. It also includes dietary advice for vitamin D. H. pylori and Cancer This updated page looks at the link between chronic H. pylori infection and the risk of stomach cancer, gastric MALT lymphoma, and other cancers. It also discusses factors that increase the chance that H. pylori infections will be harmful and the risks of cancer after treatment to get rid of it. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892